Booster Shots More Effective During Omicron Emergence Period
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Booster doses seem effective for the severe...
Read MoreJan 27, 2022
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — Booster doses seem effective for the severe...
Read MoreJan 27, 2022
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — From August 2020 through September 2021, about 7...
Read MoreJan 27, 2022
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — From August 2020 through September 2021, about 7...
Read MoreJan 25, 2022
MONDAY, Jan. 24, 2022 (HealthDay News) — Schools should stock the opioid overdose antidote...
Read MoreJan 25, 2022
MONDAY, Jan. 24, 2022 (HealthDay News) — COVID-19 testing requirements for vaccinated people...
Read MoreJan 25, 2022
MONDAY, Jan. 24, 2022 (HealthDay News) — The U.S. Food and Drug Administration may soon...
Read MoreJan 24, 2022
MONDAY, Jan. 24, 2022 (HealthDay News) — The COVID-19 pandemic is having a profound impact...
Read MoreJan 24, 2022
MONDAY, Jan. 24, 2022 (HealthDay News) — Vaccination and previous COVID-19 infection were...
Read MoreJan 24, 2022
Recent evidence suggests psychosocial stressors stemming from coronavirus disease 2019 (COVID-19) exposure and public health recommendations and policies have exacerbated eating disorder symptoms. Consequentially, eating...
Read MoreJan 24, 2022
There is known variation in perioperative mortality rates across hospitals. However, the extent to which this variation is associated with hospital-level differences in longer-term survival has not been characterized.To evaluate...
Read MoreJan 24, 2022
Cystic fibrosis-related liver disease (CFLD) is the leading cause of death in cystic fibrosis (CF), after pulmonary disease. To improve identification and management of this condition requires an understanding of the underlying...
Read MoreJan 24, 2022
Patients with epithelial ovarian cancer (EOC), treated with niraparib maintenance, present with haematological and gastrointestinal toxicities. Limited data exist on niraparib safety assessment.To evaluate niraparib safety...
Read MoreJan 24, 2022
The mental health burden for the general population due to the COVID-19 pandemic has been highlighted. Evidence on effective, easily accessible public health interventions to reduce worry, a major transdiagnostic risk-factor...
Read MoreJan 24, 2022
Leukotoxin A (LtxA) is the major virulence factor of an oral bacterium known as (). LtxA is associated with elevated levels of anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA) patients. LtxA targets...
Read MoreJan 24, 2022
To investigate the prevalence of SARS-CoV-2-associated conjunctivitis among patients presenting with conjunctivitis to ophthalmology clinics in the absence of respiratory symptoms suggesting COVID-19 during the first year of the...
Read MoreJan 24, 2022
Ferroptosis is a newly identified form of regulated cell death driven by iron-dependent phospholipid peroxidation and oxidative stress. Ferroptosis has distinct biological and morphology characteristics, such as shrunken...
Read MoreJan 24, 2022
In this study, we investigated the possibility of predicting expression levels of programmed death-ligand 1 (PD-L1) using radiomic features of intratumoral and peritumoral tumors on computed tomography (CT) images. We...
Read MoreJan 24, 2022
To examine the prevalence of temporomandibular joint disorders (TMJD) in COVID-19 confirmed patients before and after adjustments for risk factors such as fibromyalgia, nocturnal bruxism, and anxiety disorders.The i2b2 database...
Read MoreJan 24, 2022
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19), emerged in December 2019 and became a devastating pandemic. Although its respiratory effects can be deadly and...
Read MoreJan 24, 2022
Globally, SARS-CoV-2 has caused significant public health burden, mainly in patients with underlying comorbidities including both communicable and noncommunicable diseases. Solid organ transplant recipients under...
Read More